<DOC>
	<DOCNO>NCT00791661</DOCNO>
	<brief_summary>A single rising dose study assess safety , tolerability , pharmacokinetics pharmacodynamics MK-1006 Japanese participant Type 2 Diabetes Mellitus ( T2DM ) . The primary hypothesis study single dose MK-1006 sufficiently safe well tolerate , base assessment clinical laboratory evaluation adverse experience , Japanese participant T2DM .</brief_summary>
	<brief_title>MK-1006 Single Dose Study Japanese Type 2 Diabetes Patients ( MK-1006-005 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Japanese male female 20 64 year age Diagnosis type 2 diabetes Patient treat diet exercise alone single oral antihyperglycemic agent Subject history type 1 diabetes mellitus Subject clinical diagnosis glaucoma Subject donate blood participate another clinical study past 12 week Subject regular user illicit drug history drug , include alcohol , abuse past 6 month</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>